A screening performed among the Korean population in a cohort of 277 PD patients and 291 controls, by sequencing all exons of GBA1, revealed five different pathogenic heterozygous GBA1 mutations in nine PD cases (3.2%). This evidence concerns the gene GBA1 and Parkinson disease.